Latest Market News

Jindalee Lithium Limited reminds eligible shareholders that its Share Purchase Plan (SPP) will close on 20 November 2025, offering shares at $0.55 each with free attaching options exercisable at $0.825. This follows a recent $8 million placement aimed at advancing key lithium projects.

NEXTDC’s 2025 AGM highlights a landmark year with 42% growth in contracted utilisation and a $6.4 billion funding base, alongside strategic board changes and a new incentive plan to secure leadership.

NEXTDC’s FY25 Annual General Meeting reveals robust financial growth, significant data centre expansions, and enhanced funding capacity to capitalise on AI infrastructure demand.

Charger Metals has initiated a 3,000m drilling program targeting a significant niobium anomaly at its Lake Johnston Lithium Project, funded by Rio Tinto Exploration. This move could unlock new battery metals potential alongside existing lithium and gold prospects.

The ACCC has decided not to oppose Southern Cross Media’s proposed acquisition of Seven West Media, citing limited competition concerns amid evolving digital media landscapes.

The ACCC has decided not to oppose Southern Cross Media’s proposed acquisition of Seven West Media, finding limited competition concerns amid evolving digital media landscapes.

ReNerve Limited’s innovative NervAlign® Nerve Cuff has secured approval for use across the US Department of Defense and Veterans Affairs healthcare systems, marking a major milestone for the Australian medtech company.

SGH Ltd reported record earnings and reaffirmed its FY26 EBIT growth guidance at its 2025 AGM, while addressing recent workplace fatalities and outlining strategic growth initiatives.

Artrya Limited has expanded its SAPPHIRE clinical study with Ascension, one of the largest US non-profit health systems, joining as the fourth major participant. This move strengthens the study’s reach and advances the evaluation of Artrya’s AI-powered Salix platform for coronary artery disease detection.

ECS Botanics has successfully raised nearly A$2 million through a placement aimed at accelerating its international expansion and product development. The move underscores growing investor confidence in the medicinal cannabis company’s strategic growth plans.

Antilles Gold has launched a substantial infill drilling program at its La Demajagua mine in Cuba, setting the stage for a Definitive Feasibility Study that could unlock enhanced resource value amid soaring gold, silver, and antimony prices.

Anteris Technologies has gained FDA approval to start patient recruitment in the US for its pivotal PARADIGM Trial, following initial European regulatory success. The company advances manufacturing and clinical readiness as it pushes toward key regulatory milestones.